MORGAN STANLEY PLC/CALL/ASTRAZENECA ADR/82.5/0.1/21.03.25 Share Price

Warrant

DE000MG0YPC1

Delayed Börse Stuttgart 09:31:52 19/06/2024 pm IST
0.49 EUR -5.77% Intraday chart for MORGAN STANLEY PLC/CALL/ASTRAZENECA ADR/82.5/0.1/21.03.25
Current month+8.33%
1 month+23.81%
Date Price Change
19/24/19 0.49 -5.77%
18/24/18 0.52 -3.70%
17/24/17 0.54 -5.26%
14/24/14 0.57 +5.56%
13/24/13 0.54 -6.90%

Delayed Quote Börse Stuttgart

Last update June 19, 2024 at 09:31 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ASTRAZENECA PLC
Issuer Morgan Stanley
WKN MG0YPC
ISINDE000MG0YPC1
Date issued 28/03/2024
Strike 82.5 $
Maturity 21/03/2025 (275 Days)
Parity 10 : 1
Emission price 0.21
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.6
Lowest since issue 0.14
Delta0.47x
Omega 6.677
Premium12.26x
Gearing14.17x
Moneyness 0.9505
Difference Strike 4.08 $
Difference Strike %+4.95%
Spread 0.05
Spread %9.26%
Theoretical value 0.5150
Implied Volatility 25.08 %
Total Loss Probability 60.31 %
Intrinsic value 0.000000
Present value 0.5150
Break even 88.03 €
Theta-0.01x
Vega0.02x
Rho0.02x

Company Profile

AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (4.4%). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).
Sector
-
More about the company

Ratings for AstraZeneca PLC

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: AstraZeneca PLC

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
157.5 USD
Average target price
174.4 USD
Spread / Average Target
+10.73%
Consensus